As a doctor, Robert Klitzman knows that healthcare providers are well-prepared to address the physical needs of patients in hospitals, but may struggle with...
Bluebird Bio, a once-promising biotech company, made headlines recently with its decision to sell itself and its portfolio of gene therapies to investment firms...